AIT Therapeutics (AITB) PT Lowered to $13 at Roth Capital; '4Q17 Recap - PPHN the Focus'
Tweet Send to a Friend
Roth Capital lowered its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
